<DOC>
	<DOCNO>NCT00408135</DOCNO>
	<brief_summary>The primary objective ass safety telithromycin ( HMR 3647 ) ( 20 % fine granule ) 1g fill sachet child infection ( Respiratory tract infection , Dermatological infection , Otorhinolaryngological infection , Dentistry/Oral surgery infection ) . Secondary objective assess clinical efficacy , bacteriological efficacy acceptability telithromycin ( 20 % fine granule ) 1g fill sachet child infection .</brief_summary>
	<brief_title>Japanese Study Evaluating Safety , Efficacy Acceptability Telithromycin Children With Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Outpatients weight 7.0 kg . For respiratory tract infection : subject diagnose mild moderate respiratory tract infection ( exclude pneumonia ) base fever ( ≥ 38°C ) CReactive Protein positive , clinical symptoms/signs , laboratory finding . For dermatological infection : subject diagnose mild moderate dermatological infection term clinical symptoms/signs laboratory finding . For otorhinolaryngological infection : subject purulent / mucopurulent rhinorrhea postrhinorrhea , subject diagnose mild moderate otorhinolaryngological infection term clinical symptoms/signs laboratory finding For dental / oral surgical infection : subject form obstructive abscess diagnose mild moderate dental / oral surgical infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Respiratory Tract Infections</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Sinusitis</keyword>
</DOC>